CAROL GRIFFITH: Open Payments
NPI 1780123562 · DAYTON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,264 in 61 payments from 15 companies in 2025. Trend: 2023 $1,264 · 2024 $1,666 · 2025 $1,264
Food & beverage: $1,264
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 14 | $391 |
| PFIZER INC. | 5 | $107 |
| Novo Nordisk Inc | 5 | $100 |
| Merck Sharp & Dohme LLC | 5 | $92 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $91 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $87 |
| Boston Scientific Corporation | 4 | $86 |
| AstraZeneca Pharmaceuticals LP | 5 | $73 |
| E.R. Squibb & Sons, L.L.C. | 4 | $58 |
| Esperion Therapeutics, Inc. | 3 | $54 |
Products named: REPATHA, Wegovy, Kerendia, JARDIANCE, VYNDAQEL, WATCHMAN FLX, NEXLETOL, VERQUVO.
Industry payments across OH — which companies pay providers there.
